367 related articles for article (PubMed ID: 23094260)
21. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
[TBL] [Abstract][Full Text] [Related]
22. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
Gando S; Nanzaki S; Sasaki S; Kemmotsu O
Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
[TBL] [Abstract][Full Text] [Related]
23. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
[TBL] [Abstract][Full Text] [Related]
24. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
Andersen MG; Hvas CL; Tønnesen E; Hvas AM
Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
[TBL] [Abstract][Full Text] [Related]
26. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
[TBL] [Abstract][Full Text] [Related]
27. Measurement of thrombus precursor protein in septic patients with disseminated intravascular coagulation and liver disease.
Song KS; Kim HK; Song JW
Haematologica; 2002 Oct; 87(10):1062-7. PubMed ID: 12368161
[TBL] [Abstract][Full Text] [Related]
28. Role of plasma high mobility group box-1 in disseminated intravascular coagulation with leukemia.
Wang M; Mei H; Kou H; Deng J; Wang H; Guo T; Hu Y
Thromb Res; 2015 Aug; 136(2):422-6. PubMed ID: 26049171
[TBL] [Abstract][Full Text] [Related]
29. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
[TBL] [Abstract][Full Text] [Related]
30. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
31. [Significance of soluble P-selectin in diagnosis of pre-disseminated intravascular coagulation state in children with severe pneumonia].
Wang CY; Song CM; Zheng QA
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):948-52. PubMed ID: 23324156
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.
Oh D; Jang MJ; Lee SJ; Chong SY; Kang MS; Wada H
Thromb Res; 2010 Jul; 126(1):18-23. PubMed ID: 20079919
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo thrombin generation patterns in septic patients with and without disseminated intravascular coagulation.
Carlier L; Hunault G; Lerolle N; Macchi L
Thromb Res; 2015 Jan; 135(1):192-7. PubMed ID: 25467085
[TBL] [Abstract][Full Text] [Related]
34. Prospective comparison of new Japanese Association for Acute Medicine (JAAM) DIC and International Society of Thrombosis and Hemostasis (ISTH) DIC score in critically ill septic patients.
Singh RK; Baronia AK; Sahoo JN; Sharma S; Naval R; Pandey CM; Poddar B; Azim A; Gurjar M
Thromb Res; 2012 Apr; 129(4):e119-25. PubMed ID: 22138415
[TBL] [Abstract][Full Text] [Related]
35. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
[TBL] [Abstract][Full Text] [Related]
36. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
37. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation.
Sivula M; Pettilä V; Niemi TT; Varpula M; Kuitunen AH
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):419-26. PubMed ID: 19581801
[TBL] [Abstract][Full Text] [Related]
38. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.
Fourrier F; Chopin C; Goudemand J; Hendrycx S; Caron C; Rime A; Marey A; Lestavel P
Chest; 1992 Mar; 101(3):816-23. PubMed ID: 1531791
[TBL] [Abstract][Full Text] [Related]
39. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.
Choi Q; Hong KH; Kim JE; Kim HK
Ann Lab Med; 2014 Mar; 34(2):85-91. PubMed ID: 24624342
[TBL] [Abstract][Full Text] [Related]
40. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study.
Gaïni S; Pedersen SS; Koldkjaer OG; Pedersen C; Møller HJ
Crit Care; 2007; 11(2):R32. PubMed ID: 17346334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
